Torrent Pharmaceuticals logo

TORNTPHARM - Torrent Pharmaceuticals Share Price

₹2566.65 10.9  0.4%

Last Trade - 13/04/21

Large Cap
Market Cap ÂŁ4.20bn
Enterprise Value ÂŁ4.64bn
Revenue ÂŁ774.6m
Position in Universe 87th / 3106
Unlock TORNTPHARM Revenue
Relative Strength (%)
1m +7.26%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -15.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
46,535 66,869 58,569 59,498 76,728 79,393 80,066 90,304 +11.3%
+13.3 +147.9 -49.6 -28.3 +5.6 +36.0 +24.3 +16.8
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, TorrentPharmaceuticals Ltd revenues increased 1% to RS60.68B. Netincome increased 31% to RS9.28B. Revenues reflect Net salesincrease of 2% to RS59.71B. Net income benefited from Otherexpenses decrease of 14% to RS14.15B (expense), Financecosts decrease of 18% to RS2.85B (expense). Dividend pershare totaled to RS20.00.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for TORNTPHARM
Graphical History



Net Income


Normalised EPS


PE Ratio Range


Dividend Yield Range

TORNTPHARM Dividend Yield Range Unlock TORNTPHARM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
Profile Summary

Torrent Pharmaceuticals Limited is engaged in the manufacture and sale of branded, as well as unbranded generic pharmaceutical products. The Company operates in the therapeutic areas of cardiovascular (CV), central nervous system (CNS), gastrointestinal, diabetology, anti-infective, anti-diabetics and pain management segments. The Company offers products in various categories, including tablets, capsule and parenteral. Its geographical segments include India and outside India. It manufactures various active pharmaceutical ingredients (APIs), such as Nicorandil, Risperidone, Venlafaxine Hydrochloride, Ropinarole Hydrochloride, Duloxetine Hydrochloride, Ormeloxifen Hydrochloride, Nebivolol Hydrochloride, Lamotrigine and Sertraline Hydrochloride. The Company's subsidiaries include Heumann Pharma GmbH & Co., Torrent Pharma GmbH, Heunet Pharma GmbH, Norispharm GmbH, Torrent Pharma (Thailand) Co. Ltd., Torrent Pharma S.R.L., Aptil Pharma Limited and Laboratories Torrent Malaysia Sdn. Bhd.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated July 15, 1972
Public Since November 3, 1994
No. of Shareholders: 37,475
No. of Employees: 12,881
Sector Healthcare
Industry Pharmaceuticals
Index S&P BSE 100 ,
Exchange National Stock Exchange of India
Shares in Issue 169,222,720
Free Float (0.0%)
Eligible for
TORNTPHARM Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for TORNTPHARM
Upcoming Events for TORNTPHARM
Frequently Asked Questions for Torrent Pharmaceuticals
What is the Torrent Pharmaceuticals share price?

As of 13/04/21, shares in Torrent Pharmaceuticals are trading at ₹2566.65, giving the company a market capitalisation of ÂŁ4.20bn. This share price information is delayed by 15 minutes.

How has the Torrent Pharmaceuticals share price performed this year?

Shares in Torrent Pharmaceuticals are currently trading at ₹2566.65 and the price has moved by 8.06% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Torrent Pharmaceuticals price has moved by -33.29% over the past year.

What are the analyst and broker recommendations for Torrent Pharmaceuticals?

Of the analysts with advisory recommendations for Torrent Pharmaceuticals, there are there are currently 6 "buy" , 9 "hold" and 2 "sell" recommendations. The overall consensus recommendation for Torrent Pharmaceuticals is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Torrent Pharmaceuticals next release its financial results?

Torrent Pharmaceuticals is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Torrent Pharmaceuticals dividend yield?

The Torrent Pharmaceuticals dividend yield is 1.44% based on the trailing twelve month period.

Does Torrent Pharmaceuticals pay a dividend?

Last year, Torrent Pharmaceuticals paid a total dividend of 37, and it currently has a trailing dividend yield of 1.44%. Looking ahead, Torrent Pharmaceuticals has not announced an ex-dividend date yet.

When does Torrent Pharmaceuticals next pay dividends?

Torrent Pharmaceuticals has yet to annouce their ex-dividend date. The historic dividend yield on Torrent Pharmaceuticals shares is currently 1.44%.

How do I buy Torrent Pharmaceuticals shares?

To buy shares in Torrent Pharmaceuticals you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Torrent Pharmaceuticals?

Shares in Torrent Pharmaceuticals are currently trading at ₹2566.65, giving the company a market capitalisation of ÂŁ4.20bn.

Where are Torrent Pharmaceuticals shares listed? Where are Torrent Pharmaceuticals shares listed?

Here are the trading details for Torrent Pharmaceuticals:

Country of listing: India
Exchange: NSI
Ticker Symbol: TORNTPHARM
What kind of share is Torrent Pharmaceuticals?

Based on an overall assessment of its quality, value and momentum, Torrent Pharmaceuticals is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Torrent Pharmaceuticals share price forecast 2021?

Shares in Torrent Pharmaceuticals are currently priced at ₹2566.65. At that level they are trading at 9.16% discount to the analyst consensus target price of 0.00.

Analysts covering Torrent Pharmaceuticals currently have a consensus Earnings Per Share (EPS) forecast of 71.545 for the next financial year.

How can I tell whether the Torrent Pharmaceuticals share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Torrent Pharmaceuticals. Over the past six months, the relative strength of its shares against the market has been -24.12%. At the current price of ₹2566.65, shares in Torrent Pharmaceuticals are trading at -2.62% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Torrent Pharmaceuticals PE Ratio?

The Torrent Pharmaceuticals PE ratio based on its reported earnings over the past 12 months is 36.54. The shares are currently trading at ₹2566.65.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Torrent Pharmaceuticals?

Torrent Pharmaceuticals's management team is headed by:

Sudhir Mehta - NEC
Samir Mehta - CHM
Mahesh Agrawal - VPR
Shailesh Haribhakti - IND
Haigreve Khaitan - IND
Ameera Shah - IND
Sudhir Menon - CFO
Nayantara Bali - IND
Jinesh Shah - EDR
Who are the major shareholders of Torrent Pharmaceuticals?

Here are the top five shareholders of Torrent Pharmaceuticals based on the size of their shareholding:

Torrent Group Corporation
Percentage owned: 71.25% (120.6m shares)
UTI Asset Management Co. Ltd. Investment Advisor
Percentage owned: 1.46% (2.48m shares)
Mirae Asset Global Investments (India) Pvt. Ltd. Investment Advisor
Percentage owned: 1.4% (2.36m shares)
Fidelity Management & Research Company LLC Investment Advisor
Percentage owned: 1.21% (2.05m shares)
Fidelity Series Emerging Markets Opportunities Fund Mutual Fund
Percentage owned: 1.1% (1.87m shares)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.